These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 8869042)
1. [A study of the expression of MDR1 gene in solid tumors. Initial results of a multicenter evaluation]. Chevillard S; Vielh P; Vallidire P; Robert J; Marie JP Bull Cancer; 1996 Aug; 83(8):626-33. PubMed ID: 8869042 [TBL] [Abstract][Full Text] [Related]
2. French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Chevillard S; Vielh P; Validire P; Marie JP; Faussat AM; Barbu V; Bayle C; Bénard J; Bonnal C; Boutonnat J; Calvo F; Charrier J; Clary A; Colosetti P; Danel-Moore L; Decrémoux P; Delvincourt C; Finat-Duclos F; Genne P; Kataki A; Kouyoumdjian JC; Lacave R; Maugard C; Merlin JL; Robert J Leukemia; 1997 Jul; 11(7):1095-106. PubMed ID: 9204997 [TBL] [Abstract][Full Text] [Related]
3. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer. Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665 [TBL] [Abstract][Full Text] [Related]
4. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides. Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384 [TBL] [Abstract][Full Text] [Related]
5. MDR1 gene expression in primary and advanced breast cancer. Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063 [TBL] [Abstract][Full Text] [Related]
6. [Multicentric evaluation of MDR phenotype in leukemia: intermediate analysis of the French study]. Perrot JY; Faussat AM; Zhou DC; Zittoun R; Robert J; Marie JP Bull Cancer; 1996 Aug; 83(8):634-40. PubMed ID: 8869043 [TBL] [Abstract][Full Text] [Related]
7. [Reversal of multi-drug resistance in ovarian cancer cell by RNA interference]. Lou JY; Peng ZL; Zheng Y; Wang H; He B; Wang HJ Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):413-6. PubMed ID: 16831368 [TBL] [Abstract][Full Text] [Related]
8. Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates. Maas RA; Bruning PF; Breedijk AJ; Top B; Peterse HL Lab Invest; 1995 Jun; 72(6):760-4. PubMed ID: 7540237 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366 [TBL] [Abstract][Full Text] [Related]
11. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response. Materna V; Pleger J; Hoffmann U; Lage H Gynecol Oncol; 2004 Jul; 94(1):152-60. PubMed ID: 15262134 [TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients. Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948 [TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of multidrug resistance in tumor cells and analytical methods for its detection]. Takemura Y; Kobayashi H; Miyachi H Rinsho Byori; 1998 Aug; 46(8):745-58. PubMed ID: 9760826 [TBL] [Abstract][Full Text] [Related]
14. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR]. Li J; Xu L; He K; Guo W; Zhu X; Zheng Y; Xia P Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032 [TBL] [Abstract][Full Text] [Related]
15. [Clinical correlations of multidrug resistance gene expression in ovarian carcinoma]. Chen X; Li L; Huang W Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):652-5. PubMed ID: 9387523 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella. Deng J; Guo Y; Jiang Z; Yang M; Li H; Wang J J Obstet Gynaecol Res; 2015 Apr; 41(4):615-22. PubMed ID: 25370788 [TBL] [Abstract][Full Text] [Related]
17. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Tsang WP; Kwok TT Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456 [TBL] [Abstract][Full Text] [Related]
18. [Experimental study of adenovirus-mediated p53 gene on the reversal of multidrug resistance in breast cancer]. He SZ; Qi XD; Zhang XM; Wang Y Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2935-7. PubMed ID: 18261311 [TBL] [Abstract][Full Text] [Related]
19. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787 [TBL] [Abstract][Full Text] [Related]
20. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells]. Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]